This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Cracking the Generics Code unravels the mystery of the DNA for success in the international generic drug markets. The key to the generics code is a synthesis of insights gained from a detailed study of twenty leading players.
A detailed analysis of these twenty companies reveals the success code of ‘Ten essential elements of a winning strategy.’ The book presents insights gleaned and gained from the game-plans employed by these twenty highly successful companies in a sustained-release capsule form.
The game-plans of these companies reflect this spirit of success, optimism, and confidence. The ten essential strategic elements of these winning gameplans are discussed in ten separate chapters. These are:
Strategic Vision
Reaching the Critical Mass
Marketing Mindset
Technology Focus
Focusing on Research
Intellectual Capital
Integrating Strategically
Internationalizing the Business
Attracting Alliances
Operational Excellence
These twenty companies’ strategies provide invaluable lessons for the discerning reader, whether he is an executive who is shaping his company’s future, or an analyst studying and measuring the corporate performance, or a management student in pursuit of understanding how companies achieve superior sustainable performance.
Cracking the Generics Code presents the continuing adventure story of about twenty international generic pharmaceutical companies from different geographies such as the US, Germany, Japan, China, India, and Jordan that are hell-bent on becoming competitive and staying competitive in Pharma’s globalized world. While these players originate from different geographical regions of the world, the principles of their strategy and their business processes towards the adaptation of change are universally applicable and, therefore, replicable.
Cracking the Generics Code, therefore, offers valuable insights in terms of what needs to be done, and more importantly, how it can be done to achieve a higher degree of competitiveness in the brave new world of globalized Pharma by showing how a bunch of never-say-die companies are doing it successfully in some parts of the globe.
In sum, Cracking the Generics Code is your single-source success manual for winning at multi-source (generic drugs) product markets!
